BioSpace News Archive

Daxor Corporation today announced that the United States Patent and Trademark Office has issued the company a new patent (U.S. Patent No. 11,204,356 B2) that protects a proprietary clinical guidance system for volume management utilizing unique volume metrics combined with treatment pathways.

CorMedix Inc. announced that CorMedix management will be participating in several upcoming investor conferences in January.

Universe Pharmaceuticals INC today announced that the Company had entered into two strategic cooperation agreements (the “Agreements”) with Jiangxi Province Institute of Materia Medica.

Vaccinex, Inc. (Nasdaq: VCNX, Vaccinex, the Company), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and neurodegenerative disease through the inhibition of SEMA4D, today reported positive interim safety data in the Phase Ib “safety run-in” segment of the KEYNOTE B84 combination study of Keytruda®.

AbbVie (NYSE: ABBV) will participate in the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022.

Perrigo Company plc (NYSE; TASE: PRGO), announced today that President and CEO, Murray S. Kessler is scheduled to present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 at 3:45 PM (EST) .

Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Dr. Helen Torley, president and chief executive officer, will present virtually at the 40th Annual J.P. Morgan Health Care Conference on Monday, January 10, 2022 at 7:30 a.m. PT/ 10:30 a.m. ET.

The somatostatin analogs market has evolved steadily from the commercial synthesis of hundreds of analogues with more selective and prolonged action in antitumor activity.

Montelukast is a leukotriene inhibitor prescribed to prevent asthma attacks in adults as well as children aged at least two years old.

Immune repertoire is the sum of T cell receptors and B cell receptors that make an organism’s adaptive immune system. It is extensively used in biomarker discovery to improve the success rate and cost-effectiveness of rational drug development.